Development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (SEARCHER): A multi-institutional observational study
Zi-Xiang Chen(Army Medical University), Tian Yang(Second Military Medical University), Lei Liang(Zhejiang Provincial People's Hospital), Feng Shen(Second Military Medical University), Ju‐Dong Li(Second Military Medical University), Jia-Le Pu(Jilin University), Yingjian Liang(Harbin Medical University), Wan Yee Lau(Chinese University of Hong Kong), Timothy M. Pawlik(The Ohio State University), Fubao Liu(Anhui Medical University), Wei‐Min Gu(Harbin Medical University), Hong Wang(Liuyang City Maternal and Child Health Hospital), Zhiyu Chen(Sichuan University), Cheng-Wu Zhang(Zhejiang Provincial People's Hospital), Chao Li(Second Military Medical University), Ya-Hao Zhou(Puer University), Li‐Hui Gu(Second Military Medical University), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Ting‐Hao Chen(National Taiwan University), Ping Wang(Shandong First Medical University), Ming-Da Wang(Second Military Medical University), Matteo Cescon(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola)
Cited by 11
Related Papers
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
|JAMA Surgery|2018|546
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209